Carbonic anhydrase inhibitors: Inhibition of cytosolic isozymes I and II with sulfamide derivatives

被引:84
作者
Casini, A
Winum, JY
Montero, JL
Scozzafava, A
Supuran, CT
机构
[1] Univ Florence, Dipartimento Chim, Chim Bioorgan Lab, I-50019 Sesto Fiorentino, Firenze, Italy
[2] Univ Montpellier 2, Ecole Natl Super Chim Montpellier, Lab Chim Biomol, UMR 5032, F-34296 Montpellier, France
关键词
D O I
10.1016/S0960-894X(03)00028-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of effective CAIs has been identified, starting from a very weak carbonic anhydrase inhibitor (CAI), sulfamide, whose X-ray crystal structure in the adduct with hCA 11 has recently been reported. A series of N,N-disubstituted- and N-substituted-sulfamides were prepared from the corresponding amines and N-(tert-butoxycarbonyl)-N-[4-(dimethylazaniumylidene)-1,4-dihydropyridin-1-ylsulfonyl]azanide or the unstable N-(tert-butoxycarbonyl)sulfamoyl chloride. The disubstituted compounds being too bulky, were ineffective as CAIs, whereas mono-substituted derivatives (incorporating aliphatic, cyclic and aromatic moieties) as well as a bis-sulfamide, behaved as micro-nanomolar inhibitors of two cytosolic isozymes, hCA I and hCA 11, responsible for critical physiological processes in higher vertebrates. Aryl-sulfamides were more effective than aliphatic derivatives. Low nanomolar inhibitors have been detected, which generally incorporated 4-substituted phenyl moieties in their molecule. This is the first example of CAIs in which low nanomolar inhibitors were generated starting from a very ineffective lead molecule. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:837 / 840
页数:4
相关论文
共 18 条
[11]  
PAQUIN AM, 1948, ANGEW CHEM-GER EDIT, V60, P316
[12]   CATALYTIC VERSATILITY OF ERYTHROCYTE CARBONIC ANHYDRASE .3. KINETIC STUDIES OF ENZYME-CATALYZED HYDROLYSIS OF P-NITROPHENYL ACETATE [J].
POCKER, Y ;
STONE, JT .
BIOCHEMISTRY, 1967, 6 (03) :668-&
[13]   PYRANENAMINES - NEW SERIES OF ANTI-ALLERGIC COMPOUNDS [J].
SNADER, KM ;
CHAKRIN, LW ;
CRAMER, RD ;
GELERNT, YM ;
MIAO, CK ;
SHAH, DH ;
VENSLAVSKY, JW ;
WILLIS, CR ;
SUTTON, BM .
JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (06) :706-714
[14]  
Supuran Claudiu T., 2001, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V1, P61, DOI 10.2174/1568013013359131
[15]   Carbonic anhydrase inhibitors and their therapeutic potential [J].
Supuran, CT ;
Scozzafava, A .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (05) :575-600
[16]   Applications of carbonic anhydrase inhibitors and activators in therapy [J].
Supuran, CT ;
Scozzafava, A .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (02) :217-242
[17]   Carbonic anhydrase inhibitors [J].
Supuran, CT ;
Scozzafava, A ;
Casini, A .
MEDICINAL RESEARCH REVIEWS, 2003, 23 (02) :146-189
[18]   N-(tert-butoxycarbonyl)-N-[4-(dimethylazaniumylidene)-1,4-dihydropyridin-1-ylsulfonyl]azanide:: A new sulfamoylating agent.: Structure and reactivity toward amines [J].
Winum, JY ;
Toupet, L ;
Barragan, V ;
Dewynter, G ;
Montero, JL .
ORGANIC LETTERS, 2001, 3 (14) :2241-2243